Global mRNA Cancer Vaccines and Therapeutics Competitive Landscape Professional Research Report 2025
Research Summary
mRNA (messenger RNA) cancer vaccines and therapeutics represent a groundbreaking approach to cancer treatment and prevention. These innovative therapies use synthetic mRNA molecules to instruct the patient＇s own cells to produce specific proteins or antigens that stimulate the immune system to recognize and target cancer cells. mRNA cancer vaccines can be tailored to an individual＇s unique cancer profile, making them a promising avenue for personalized cancer treatment. By training the immune system to recognize and attack cancer cells, these vaccines hold the potential to provide effective, targeted, and less invasive treatment options. Additionally, mRNA technology has gained prominence for its role in the development of COVID-19 vaccines, underscoring its versatility and transformative potential in the field of medicine and disease prevention.
According to DIResearch's in-depth investigation and research, the global mRNA Cancer Vaccines and Therapeutics market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of mRNA Cancer Vaccines and Therapeutics include Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics, In-Cell-Art, eTheRNA, Ethris, Tiba Biotechnology etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of mRNA Cancer Vaccines and Therapeutics. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global mRNA Cancer Vaccines and Therapeutics market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the mRNA Cancer Vaccines and Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of mRNA Cancer Vaccines and Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of mRNA Cancer Vaccines and Therapeutics Include:
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
mRNA Cancer Vaccines and Therapeutics Product Segment Include:
Vaccines
Therapeutics
mRNA Cancer Vaccines and Therapeutics Product Application Include:
Adenocarcinoma
Mucinous Carcinoma
Adenosquamous Carcinoma
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global mRNA Cancer Vaccines and Therapeutics Industry PESTEL Analysis
Chapter 3: Global mRNA Cancer Vaccines and Therapeutics Industry Porter’s Five Forces Analysis
Chapter 4: Global mRNA Cancer Vaccines and Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global mRNA Cancer Vaccines and Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa mRNA Cancer Vaccines and Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global mRNA Cancer Vaccines and Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 mRNA Cancer Vaccines and Therapeutics Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 mRNA Cancer Vaccines and Therapeutics Product by Type
- 1.2.1 Vaccines
- 1.2.2 Therapeutics
- 1.3 mRNA Cancer Vaccines and Therapeutics Product by Application
- 1.3.1 Adenocarcinoma
- 1.3.2 Mucinous Carcinoma
- 1.3.3 Adenosquamous Carcinoma
- 1.3.4 Others
- 1.4 Global mRNA Cancer Vaccines and Therapeutics Market Size Analysis (2020-2032)
- 1.5 mRNA Cancer Vaccines and Therapeutics Market Development Status and Trends
- 1.5.1 mRNA Cancer Vaccines and Therapeutics Industry Development Status Analysis
- 1.5.2 mRNA Cancer Vaccines and Therapeutics Industry Development Trends Analysis
- 2 mRNA Cancer Vaccines and Therapeutics Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 mRNA Cancer Vaccines and Therapeutics Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global mRNA Cancer Vaccines and Therapeutics Market Analysis by Regions
- 4.1 mRNA Cancer Vaccines and Therapeutics Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global mRNA Cancer Vaccines and Therapeutics Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global mRNA Cancer Vaccines and Therapeutics Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global mRNA Cancer Vaccines and Therapeutics Revenue Forecast by Region (2026-2032)
- 5 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type and Application
- 5.1 Global mRNA Cancer Vaccines and Therapeutics Market Size by Type (2020-2032)
- 5.2 Global mRNA Cancer Vaccines and Therapeutics Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 6.4 North America mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 6.5 North America mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 7.4 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 7.5 Europe mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 8.4 China mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 9.4 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 9.5 APAC (excl. China) mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 10.4 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 10.5 Latin America mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Type
- 11.4 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Application
- 11.5 Middle East & Africa mRNA Cancer Vaccines and Therapeutics Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global mRNA Cancer Vaccines and Therapeutics Market Revenue by Key Manufacturers (2021-2025)
- 12.2 mRNA Cancer Vaccines and Therapeutics Competitive Landscape Analysis and Market Dynamic
- 12.2.1 mRNA Cancer Vaccines and Therapeutics Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Moderna Therapeutics
- 13.1.1 Moderna Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.1.3 Moderna Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 CureVac
- 13.2.1 CureVac Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 CureVac mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.2.3 CureVac mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Translate Bio
- 13.3.1 Translate Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Translate Bio mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.3.3 Translate Bio mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 BioNTech
- 13.4.1 BioNTech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 BioNTech mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.4.3 BioNTech mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Sangamo Therapeutics
- 13.5.1 Sangamo Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.5.3 Sangamo Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Argos Therapeutics
- 13.6.1 Argos Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.6.3 Argos Therapeutics mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.7 In-Cell-Art
- 13.7.1 In-Cell-Art Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.7.2 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.7.3 In-Cell-Art mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.8 eTheRNA
- 13.8.1 eTheRNA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.8.2 eTheRNA mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.8.3 eTheRNA mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.9 Ethris
- 13.9.1 Ethris Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.9.2 Ethris mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.9.3 Ethris mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.10 Tiba Biotechnology
- 13.10.1 Tiba Biotechnology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.10.2 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Product Portfolio
- 13.10.3 Tiba Biotechnology mRNA Cancer Vaccines and Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 mRNA Cancer Vaccines and Therapeutics Industry Chain Analysis
- 14.2 mRNA Cancer Vaccines and Therapeutics Industry Raw Material and Suppliers Analysis
- 14.2.1 mRNA Cancer Vaccines and Therapeutics Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 mRNA Cancer Vaccines and Therapeutics Typical Downstream Customers
- 14.4 mRNA Cancer Vaccines and Therapeutics Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook